GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Top Insider Buy Companies: Modelez International, Starbucks Corporation, Valeant Pharmaceuticals International, Annaly Capital Management and Capine

August 27, 2013 | About:
guruek

guruek

80 followers
According to GuruFocus Insider Data, these are the largest insider buys during the past week: Modelez International Inc. (MDLZ), Starbucks Corporation (SBUX), Valeant Pharmaceuticals International Inc. (VRX), Annaly Capital Management Inc. (NLY), and Calpine Corp. (CPN).

The overall trend of insiders is illustrated in the chart below:



Mondelez International Inc. (MDLZ): Director Lewis Booth Bought 6,470 Shares

Director of Mondelez International Inc., Lewis W K Booth, bought 6,470 shares on Aug. 20 at an average price of $31.32. Mondelez International was formerly known as Kraft Foods Inc. Mondelez International Inc has a market cap of $55.77 billion; its shares were traded at around $31.32 with a P/E ratio of 29.50 and P/S ratio of 2.16. The dividend yield of Mondelez International Inc stocks is 2.17%. Mondelez International Inc had an annual average earnings growth of 0.8% over the past 10 years.

On Aug. 7, Mondelez International, Inc. reported second quarter and first half 2013 results. Net revenues were $8.6 billion, up 0.8 percent. Last week, Director Lewis W K Booth bought 6,470 shares of MDLZ stock. Operating income was $0.9 billion, down 7.7 percent, and operating income margin was 10.1 percent.

Starbucks Corporation (SBUX): Director Mellody Hobson Bought 141,573 Shares

Director of Starbucks Corporation, Mellody L Hobson, bought 141,573 shares on Aug. 19 at an average price of $71.97. Starbucks Corporation was formed in 1985. The Company purchases and roasts high-quality whole bean coffees and sells them, along with fresh, rich-brewed coffees, Italian-style espresso beverages, cold blended beverages, complementary food items, a selection of teas, and beverage-related accessories and equipment, through its company-operated retail stores. Starbucks Corporation has a market cap of $54.08 billion; its shares were traded at around $71.97 with a P/E ratio of 34.36 and P/S ratio of 3.80. The dividend yield of Starbucks Corporation stocks is 1.17%. Starbucks Corporation had an annual average earnings growth of 14% over the past 10 years.

GuruFocus rated Starbucks Corporation the business predictability rank of 3-star.

On July 25, Starbucks Corporation reported financial results for its 13-week fiscal third quarter ended June 30, 2013. Total net revenues increased 13% to $3.7 billion. Global comparable store sales grew 8% driven by 7% growth in traffic; all regions accelerated over Q2. Consolidated operating income increased 25% to $615.2 million. Consolidated operating margin expanded 150 basis points to 16.4%.

Last week, Director Mellody L Hobson bought 141,573 shares of SBUX stock. CFO and CAO Troy Alstead and Chairman, President and CEO Howard D Schultz sold shares this month. Director Robert M Gates bought 3,300 shares in May. EVP, Gen. Counsel & Secretary Lucy Lee Helm, Director James G Jr Shennan, and Pres, Americas and US Clifford Burrows sold shares in May.

Valeant Pharmaceuticals International Inc. (VRX): EVP, GC and Corporate Secretary Robert Roswell Chai-onn Bought 5,032 Shares

EVP, GC and Corp. Secretary of Valeant Pharmaceuticals International Inc. Robert Roswell Chai-onn bought 5,032 shares on Aug. 23 at an average price of $99.52. Valeant Pharmaceuticals International was formerly known as Biovail Corporation. Valeant Pharmaceuticals International Inc. has a market cap of $33.09 billion; its shares were traded at around $99.52 with a P/E ratio of 1050.50 and P/S ratio of 7.63. Valeant Pharmaceuticals International Inc. had an annual average earnings growth of 4.2% over the past 10 years.

On August 7, Valeant Pharmaceuticals International Inc. reported results for the 2nd quarter of 2013. Valeant's total revenues were $1.1 billion, up 34% compared to the second quarter of 2012, and product revenues were $1.06 billion, up 43% versus the year-ago quarter. The company reported net income of $11 million for the second quarter of 2013, or $0.03 per diluted share. On a Cash EPS basis, adjusted income was $421 million, or $1.34 per diluted share.

This month, EVP, GC and Corp. Secretary Robert Roswell Chai-onn, Senior Officer Brian Matheison Stolz, Senior Officer Laizer Kornwasser, and EVP, Company Group Chairman Laizer Kornwasser shares of VRX stock.

Annaly Capital Management, Inc. (NLY): Director Kevin Brady Bought 9,000 Shares

Director of Annaly Capital Management, Inc., Kevin Brady, bought 9,000 shares on Aug. 20 at an average price of $11.42. Annaly Capital Management, Inc is a Maryland corporation that commenced operations on February 18, 1997. Annaly Capital Management, Inc. has a market cap of $10.82 billion; its shares were traded at around $11.42 with a P/E ratio of 3.31 and P/S ratio of 3.04. The dividend yield of Annaly Capital Management, Inc. stocks is 15.76%.

On August 7, Annaly Capital Management Inc. reported GAAP net income for the quarter ended June 30, 2013 of $1.6 billion or $1.71 per average common share as compared to GAAP net income of $870.3 million or $0.90 per average common share for the quarter ended March 31, 2013, and GAAP net loss of $91.2 million or $0.10 per average common share for the quarter ended June 30, 2012.

This month, Chairman of Board & CEO Wellington Denahan, Director Kevin Brady, Co-CIO Kristopher Robert Konrad, and Director John H Schaefer bought shares of NLY stock.

Calpine Corp (CPN): Director David C Merritt Bought 10,000 Shares



Director of Calpine Corp David C Merritt bought 10,000 shares on Aug. 19 at an average price of $19.49. Calpine Corp is a Delaware corporation, which was established in 1984. Calpine Corp has a market cap of $8.57 billion; its shares were traded at around $19.49 with a P/E ratio of 26.18 and P/S ratio of 1.44.

On Jul. 25, Calpine Corporation reported second quarter 2013 Adjusted EBITDA of $343 million, compared to $403 million in the prior year period, and Adjusted Free Cash Flow of $38 million, or $0.08 per diluted share, compared to $87 million, or $0.19per diluted share, in the prior year period. Net Loss for the second quarter of 2013 was $70 million, or$0.16 per diluted share, compared to $329 million, or $0.69 per diluted share, in the prior year period. Net Loss, As Adjusted2, for the second quarter of 2013 was $33 million compared to Net Income, As Adjusted2, of $14 million in the prior year period.

Last week, Director David C Merritt bought 10,000 shares of CPN stock. Director Robert A Jr Mosbacher sold 8,000 shares last week. 10% Owner Advisory Corp Spo sold 16,000,000 shares in May. 10% Owner Energy Partners Master Luminus and 10% Owner Asset Partners Lp Vega sold shares in April.

  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 3.0/5 (2 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide